XpresSpa Group (NASDAQ:XSPA – Get Rating) released its earnings results on Tuesday. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.03), MarketWatch Earnings reports. XpresSpa Group had a negative net margin of 34.93% and a negative return on equity of 17.37%. Shares of NASDAQ:XSPA traded up […]
- Patients with axial spondyloarthritis (axSpA), who achieve sustained remission, benefit from continued CIMZIA (certolizumab pegol) treatment either at the full or reduced maintenance dose